Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in Immunology and Immuno-techniques : Updated Concepts and Recent Applications / / edited by Alok Das Mohapatra, Priyadarshi S. Sahu
| Advances in Immunology and Immuno-techniques : Updated Concepts and Recent Applications / / edited by Alok Das Mohapatra, Priyadarshi S. Sahu |
| Autore | Das Mohapatra Alok |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (309 pages) |
| Disciplina | 616.079 |
| Altri autori (Persone) | SahuPriyadarshi S |
| Collana | Interdisciplinary Biotechnological Advances |
| Soggetto topico |
Immunology
Biotechnology Biology - Technique Immunotherapy Biological Techniques Applied Immunology |
| ISBN |
9789819755080
9789819755073 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Immunologic Basis of Immuno-therapeutics and Vaccines: Present Approaches and Future Perspectives -- Chapter 2. Blocking Co-inhibitory Receptors: A Promising Cancer Immunotherapy Strategy -- Chapter 3. Neoepitope-based Cancer Vaccines: Principle and Applications -- Chapter 4. Bispecific Antibodies: An Emerging Concept in Antibody-based Cancer Therapies -- Chapter 5. Progresses and Challenges in HIV Vaccine -- Chapter 6. Neurobiological Mechanisms of Maternal Immune Activation-induced Neurodevelopmental Disorders: A Serotonin Model -- Chapter 7. Immunopharmacogenomics: Challenges and Future Prospects -- Chapter 8. Immunology Encounters Nano-technology: Recent Developments and Future Prospects of Nano-based Drug Delivery Systems -- Chapter 9. Novel Drug Targets in Neuro-immune Disorders -- Chapter 10. The Role of Host Genetics in the Susceptibility, Severity, and Immune Response to SARS-CoV-2 -- Chapter 11. Immuno Metabolic Interplay in Health and Disease -- Chapter 12. Role of Human Milk Immune Modulators on Infant’s Health. |
| Record Nr. | UNINA-9910908366503321 |
Das Mohapatra Alok
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Convalescent Plasma and Other Antibody Therapies for Infectious Diseases : Lessons learned from COVID-19 and Future Prospects / / edited by Nigel Paneth, Michael J. Joyner, Arturo Casadevall
| Convalescent Plasma and Other Antibody Therapies for Infectious Diseases : Lessons learned from COVID-19 and Future Prospects / / edited by Nigel Paneth, Michael J. Joyner, Arturo Casadevall |
| Autore | Paneth Nigel |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (375 pages) |
| Disciplina | 615.37 |
| Altri autori (Persone) |
JoynerMichael J
CasadevallArturo |
| Collana | Current Topics in Microbiology and Immunology |
| Soggetto topico |
Immunology
Medical microbiology Pharmacology Virology Applied Immunology Medical Microbiology |
| ISBN | 3-031-87167-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | THE LOGIC AND HISTORY OF PASSIVE IMMUNITY AND ANTIBODY THERAPIES -- A BRIEF HISTORY OF POLYCLONAL ANTIBODY THERAPIES AGAINST BACTERIAL AND VIRAL DISEASES BEFORE COVID-19 -- THE IMPORTANCE OF ANTIBODY TITER DETERMINATION TO THE EFFECTIVE USE OF CONVALESCENT PLASMA -- CONVALESCENT PLASMA AND THE US EXPANDED ACCESS PROGRAM: A PERSONAL NARRATIVE -- The safety profile of COVID-19 convalescent plasma -- The Importance of Geographic Proximity of Convalescent Plasma Donors -- Evidence for the efficacy of COVID-19 convalescent plasma -- CONVALESCENT PLASMA FOR IMMUNOCOMPROMISED PATIENTS -- MONOCLONAL ANTIBODY THERAPIES AGAINST SARS-CoV-2: PROMISES AND REALITIES -- Hyperimmune Globulins in COVID-19 -- THE ROLE OF THE PATIENT ADVOCATE DURING A PANDEMIC: THE CASE OF CONVALESCENT PLASMA -- BLOOD BANKING CAPACITY IN LOW-AND MIDDLE-INCOME COUNTRIES: COVID-19 CONVALESCENT PLASMA IN CONTEXT -- HEMOCLEAR: A PRACTICAL AND COST-EFFECTIVE ALTERNATIVE TO CONVENTIONAL CONVALESCENT PLASMA RETRIEVAL METHODS -- GENERATING THE EVIDENCE BASE FOR CONVALESCENT PLASMA USE FOR A NEW INFECTIOUS DISEASE -- CONVALESCENT PLASMA AND OTHER ANTIBODY THERAPIES FOR INFECTIOUS DISEASES – LESSONS LEARNED FROM COVID-19 AND FUTURE PROSPECTS -- MONOCLONAL ANTIBODIES AND HYPERIMMUNE IMMUNOGLOBULINS IN THE NEXT PANDEMIC -- USING PASSIVE ANTIBODY THERAPIES IN THE NEXT PANDEMIC. |
| Record Nr. | UNINA-9911034952703321 |
|
Paneth Nigel
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Curing Disease from the Ground Up : How to Operate a Biotechnology Business Incubator / / by Timothy M. Block
| Curing Disease from the Ground Up : How to Operate a Biotechnology Business Incubator / / by Timothy M. Block |
| Autore | Block Timothy M |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (124 pages) |
| Disciplina | 610.72 |
| Soggetto topico |
Medicine - Research
Biology - Research Immunology Biotechnology Medical sciences Biology Biomedical Research Applied Immunology Health Sciences Biological Sciences |
| ISBN |
9783031561481
9783031561474 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Starting it: Why I started a life sciences incubator -- 2. Business incubators and entrepreneurship -- 3. Pennsylvania Biotechnology Center: A How- to Manual. |
| Record Nr. | UNINA-9910872194903321 |
|
Block Timothy M
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges : Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis / / edited by Myron Christodoulides
| Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges : Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis / / edited by Myron Christodoulides |
| Autore | Christodoulides Myron |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (VI, 344 p. 28 illus., 27 illus. in color.) |
| Disciplina | 616.9041 |
| Soggetto topico |
Medical microbiology
Vaccines - Biotechnology Biomaterials Immunology Biotechnology Medical Microbiology Biomaterials-Vaccines Applied Immunology |
| ISBN | 3-031-24355-2 |
| Classificazione | MED044000MED052000SCI010000SCI013000TEC021000 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface by Prof Myron Christodoulides, University of Southampton, UK.-1. Introduction chapter on the VALIDATE network -- (Prof Helen McShane, Director Oxford NIHR Biomedical Research Centre, University of Oxford, UK and Samantha Vermaak, The Jenner Institute Laboratories, Oxford, UK) -- Part I: Leprosy -- 2. Leprosy challenges to vaccine developers -- (Dr Hua Wang, University of Glasgow, UK) -- 3. Leprosy vaccine development -- (Dr Khushboo Borah, University of Surrey, UK) -- Part II: Tuberculosis -- 4. Biomarkers in tuberculosis vaccine development -- (Dr Kenneth Akwue, University of the Witwatersrand, Johannesburg, South Africa) -- 5. Tuberculosis correlates of protection (Dr Rachel Tanner, The Jenner Institute Laboratories, Oxford, UK), -- Animal models for tuberculosis (Dr. Hao Li, China Agricultural University, Beijing, China) -- 7. BCG vaccination -- (Dr Hazel Morrison, The Jenner Institute Laboratories, Oxford, UK) -- 8. Vaccination strategies for Buruli ulcer disease (Dr Rachel Simmonds, University of Surrey, UK) -- 9. Fermentation in vaccine development (BCG) (Dr. Joanna Bacon, Public Health England, UK Government, London, UK) -- Part III: Leishmaniasis: 10. Human leishmaniasis vaccination -- (Dr Ali Bordbar, Institute Pasteur of Iran, Tehran, Iran) -- 11. Aspects of human leishmaniasis vaccine use -- (Dr Olayinka Osuolale, Elizade University, Ilara-Mokin, Nigeria) -- 12. Human challenge model for developing leishmaniasis vaccines (Prof Paul Kaye, University of York, UK) -- 13. Canine leishmaniasis vaccines -- (Prof Eduardo Coelho, Federal University of Minas Gerais, Belo Horizonte, Brazil and Prof Myron Christodoulides, University of Southampton, UK) -- Part IV: Melioidosis -- 14. Vaccines for melioidosis (Prof Chiranjay Mukhopadhyay, Kasturba Medical College, Manipal, India) -- 15. West Africa burden of disease (Dr Tukur Ismail, Zamfara State Primary Healthcare Board, Gusau, Nigeria). |
| Record Nr. | UNINA-9910682530103321 |
|
Christodoulides Myron
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Applied Immunology
(4)
- Immunology (4)
- Biotechnology (3)
- Medical Microbiology (2)
- Medical microbiology (2)